Search results
Found 15 matches for
Results from an insight review commissioned by the Wellcome Trust, highlights what is currently known about the benefits and risks of using selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression and anxiety in young people.
New international guidelines for the treatment of schizophrenia
2 April 2025
Researchers from all regions of the UN have developed a set of consensus guidelines for the treatment of schizophrenia.
Anticholinergic medications given to people with psychosis could worsen memory
26 February 2025
Medications routinely given to people experiencing psychosis could be worsening some of their cognitive function, including memory and concentration, according to a new analysis of existing research.
In memoriam: Professor Tim Crow OBE
26 November 2024
The influential and pioneering psychiatric researcher Professor Timothy Crow OBE, who was a member of the Department of Psychiatry at Oxford, has died at the age of 86.
Artificial intelligence (AI) language tools could be used to help detect mental health conditions
10 October 2023
Scientists are using AI to detect language differences in people with mental health difficulties that could eventually be used to help diagnose and monitor psychiatric conditions.
Prioritising the children of parents with severe mental illness
24 July 2023
The needs of children whose parents have severe mental illness should be prioritised, according to a new paper written by a consortium of international experts.
New study reveals clinical instability can predict psychiatric hospitalisation
28 March 2023
For patients with psychiatric conditions, data shows that both illness severity and instability are key factors in predicting their future risk of hospitalisation.
Major trials to test effectiveness of cannabidiol on psychosis
16 February 2023
Global study involving three clinical trials will investigate the effectiveness of cannabidiol (CBD) in treating people with psychosis or psychotic symptoms, thanks to a multi-million pound grant to Oxford University.
Review Highlights Risk Factors Associated with Violence in Schizophrenia
20 January 2022
Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).
Investigating New Treatment for Schizophrenia
21 January 2021
A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.
First Female Professor of Psychiatry in the Department
20 August 2019
Professor Belinda Lennox has been given the title of Professor of Psychiatry in the 2019 Recognition of Distinction Exercise at the University of Oxford.
Virtual Reality Could Transform Psychological Therapy in the NHS
27 June 2019
A new clinical trial is testing a virtual reality (VR) based psychological therapy for people with severe mental health difficulties. gameChange is the largest ever clinical trial of virtual reality for a mental health disorder. Automated delivery of therapy using VR has potential to transform NHS provision of psychological therapy.